L. Daniel Browne, CEO and President at Revance Therapeutics, Inc. (RVNC), sold 15,324 shares at $26.16 ($401K) on 2017-10-18, disclosed to the SEC on 2017-10-20.
Open-market sale of $401k RVNC by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.16 | 7,662 | $200K | 50.0% |
| 2 | $26.16 | 7,662 | $200K | 50.0% |
| Total | $26.16 avg | 15,324 | $401K | 100% |
| Filing → |
| RVNC | SELL | 2018-03-16 | $376K | — | Filing → |
| RVNC | SELL | 2018-03-09 | $1.7M | — | Filing → |
| RVNC | SELL | 2017-11-24 | $190K | — | Filing → |